Log in to save to my catalogue

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic...

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733094555

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response

About this item

Full title

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response

Publisher

England: Future Medicine Ltd

Journal title

Pharmacogenomics, 2010-06, Vol.11 (6), p.747-761

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

The identification of predictive markers of response to chemoradiotherapy treatment remains a promising approach for patient management in order to obtain the best response with minor side effects. Initially, we investigated whether the analysis of several markers previously studied and others not yet evaluated could predict response to 5-fluoroura...

Alternative Titles

Full title

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_733094555

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733094555

Other Identifiers

ISSN

1462-2416

E-ISSN

1744-8042

DOI

10.2217/pgs.10.51

How to access this item